Summary ?
GeneID84833
SymbolUSMG5
SynonymsDAPIT|HCVFTP2|bA792D24.4
Descriptionup-regulated during skeletal muscle growth 5 homolog (mouse)
ReferenceMIM:615204|HGNC:HGNC:30889|Ensembl:ENSG00000173915|HPRD:18277|Vega:OTTHUMG00000018984
Gene typeprotein-coding
Map location10q24.33
Pascal p-value0.003
Fetal beta-1.173
eGeneMyers' cis & trans
Meta
SupportG2Cdb.humanPSD
G2Cdb.humanPSP

Gene in Data Sources
Gene set name Method of gene setDescriptionInfo
CV:PGCnpGenome-wide Association StudyGWAS
DMG:Wockner_2014Genome-wide DNA methylation analysisThis dataset includes 4641 differentially methylated probes corresponding to 2929 unique genes between schizophrenia patients (n=24) and controls (n=24). 1
LK:YESGenome-wide Association StudyThis data set included 99 genes mapped to the 22 regions. The 24 leading SNPs were also included in CV:Ripke_2013

Section I. Genetics and epigenetics annotation

@Differentially methylated gene

ProbeChromosomePositionNearest geneP (dis)Beta (dis)FDR (dis)Study
cg0416584010105156204USMG5;PDCD114.025E-4-0.1830.044DMG:Wockner_2014

@eQTL annotation

SNP IDChromosomePositioneGeneGene Entrez IDpvalueqvalueTSS distanceeQTL type
rs7088711chr10104559265USMG5848332.538E-5cis
rs2482506chr10104563742USMG5848338.631E-7cis
rs4919690chr10104616499USMG5848330.11cis
rs4409766chr10104616662USMG5848330.1cis
rs3740393chr10104636654USMG5848330.05cis
rs3740390chr10104638479USMG5848330.08cis
rs12413409chr10104719095USMG5848330.01cis
rs17115419chr10104834875USMG5848330.07cis
rs11191560chr10104869037USMG5848330.03cis
rs1163249chr10104909889USMG5848332.722E-4cis
rs7913461chr10105001324USMG5848332.327E-10cis
rs1891292chr10105001509USMG5848331.026E-9cis
rs1163073chr10105022933USMG5848331.494E-21cis
rs10883855chr10105092446USMG5848330cis
rs11191686chr10105187745USMG5848332.788E-8cis
rs11191688chr10105192569USMG5848334.714E-5cis
rs7088711chr10104559265USMG5848330trans
rs2482506chr10104563742USMG5848331.634E-4trans
rs1163249chr10104909889USMG5848330.02trans
rs7913461chr10105001324USMG5848335.737E-8trans
rs1891292chr10105001509USMG5848332.536E-7trans
rs1163073chr10105022933USMG5848332.272E-19trans
rs11191686chr10105187745USMG5848336.526E-6trans
rs11191688chr10105192569USMG5848330.01trans

Section II. Transcriptome annotation

General gene expression (GTEx)

Not available

Gene expression during devlopment (BrainCloud)

Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.

Gene expression of temporal and spatial changes (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.

No co-expressed genes in brain regions


Section V. Pathway annotation

Pathway namePathway size# SZGR 2.0 genes in pathwayInfo
WAMUNYOKOLI OVARIAN CANCER LMP UP 265158All SZGR 2.0 genes in this pathway
WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 UP 13784All SZGR 2.0 genes in this pathway
MCBRYAN PUBERTAL BREAST 6 7WK DN 7954All SZGR 2.0 genes in this pathway
LASTOWSKA NEUROBLASTOMA COPY NUMBER DN 800473All SZGR 2.0 genes in this pathway
LOPEZ MBD TARGETS 957597All SZGR 2.0 genes in this pathway
CAFFAREL RESPONSE TO THC 24HR 5 DN 5935All SZGR 2.0 genes in this pathway
ROZANOV MMP14 TARGETS UP 266171All SZGR 2.0 genes in this pathway
JIANG AGING HYPOTHALAMUS UP 4731All SZGR 2.0 genes in this pathway
KRIEG KDM3A TARGETS NOT HYPOXIA 208107All SZGR 2.0 genes in this pathway